Oliver Artz
Impact in
- Biotechnology top 10%
- Cancer Research and Treatments
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 6
- Colorectal Cancer Treatments and Studies 1
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Ute Hoecker (2 shared papers)Ullas V. Pedmale (1 shared paper)Aashish Ranjan (1 shared paper)Stefan Andreas Rensing (1 shared paper)Leonie Kokkelink (1 shared paper)Ryosuke Hayama (1 shared paper)Lisa Leson (1 shared paper)Margaret Ahmad (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Annals of Oncology (2 papers)Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (1 paper)New Phytologist (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Oliver Artz
12 papers receiving 385 citations
Oliver Artz's Hit Papers
Peers
Comparison fields: 5 of 39
- Biotechnology 53
- Oncology 161
- Biomaterials 33
- Pathology and Forensic Medicine 45
- Molecular Biology 100
Countries citing papers authored by Oliver Artz
This map shows the geographic impact of Oliver Artz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Artz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Artz more than expected).
Fields of papers citing papers by Oliver Artz
This network shows the impact of papers produced by Oliver Artz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Artz. The network helps show where Oliver Artz may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Artz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses Hit paper breakdown → | 2023 | 176 |
| 2 | Nonoperative Management of Mismatch Repair–Deficient Tumors Hit paper breakdown → | 2025 | 86 |
| 3 | 2024 | 45 | |
| 4 | 2019 | 20 | |
| 5 | 2022 | 18 | |
| 6 | 2016 | 16 | |
| 7 | 2015 | 8 | |
| 8 | 2025 | 7 | |
| 9 | 2024 | 6 | |
| 10 | 2025 | 4 | |
| 11 | 2024 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2025 | 0 |
About Oliver Artz
Oliver Artz is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Plant Science and Biotechnology, having authored 13 papers that have together received 388 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Light effects on plants (3 papers), Cancer Genomics and Diagnostics (2 papers), Genetic factors in colorectal cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (1 paper), Acute Myeloid Leukemia Research (1 paper), Cellular Mechanics and Interactions (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Biotechnology (53 citations), Oncology (161 citations), Biomaterials (33 citations), Pathology and Forensic Medicine (45 citations) and Molecular Biology (100 citations). Oliver Artz has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Ute Hoecker, Ullas V. Pedmale, Aashish Ranjan, Stefan Andreas Rensing, Leonie Kokkelink, Ryosuke Hayama, Lisa Leson, Margaret Ahmad, Andrea Cercek and Michael Lammers. Their work appears in journals such as Clinical Cancer Research, Annals of Oncology, Journal of Clinical Investigation, Journal of Clinical Oncology and New Phytologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.